The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 30, 2019

Filed:

Feb. 10, 2012
Applicants:

Walter Mier, Bensheim, DE;

Stephan Urban, Neustadt/Weinstrasse, DE;

Stefan Mehrle, Limburgerhof, DE;

Uwe Haberkorn, Schweitzingen, DE;

Thomas Müller, Schriesheim, DE;

Vasileios Askoxylakis, Wilhelmsfeld, DE;

Inventors:

Walter Mier, Bensheim, DE;

Stephan Urban, Neustadt/Weinstrasse, DE;

Stefan Mehrle, Limburgerhof, DE;

Uwe Haberkorn, Schweitzingen, DE;

Thomas Müller, Schriesheim, DE;

Vasileios Askoxylakis, Wilhelmsfeld, DE;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 51/08 (2006.01); A61K 38/00 (2006.01); A61K 49/00 (2006.01); A61K 49/08 (2006.01); A61K 49/14 (2006.01); C07K 14/005 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
A61K 51/088 (2013.01); A61K 49/0056 (2013.01); A61K 49/085 (2013.01); A61K 49/14 (2013.01); C07K 14/005 (2013.01); C12N 7/00 (2013.01); A61K 38/00 (2013.01); C07K 2319/50 (2013.01); C12N 2730/10122 (2013.01); Y02A 50/409 (2018.01); Y02A 50/411 (2018.01); Y02A 50/423 (2018.01); Y02A 50/463 (2018.01);
Abstract

The present invention relates to hydrophobic modified peptides for the specific delivery of labels to the liver, preferably to hepatocytes, in vitro as well as in vivo. The present invention relates to pharmaceutical compositions comprising said hydrophobic modified peptide(s) and the label(s) to be specifically delivered to the liver. The present invention furthermore relates to the diagnostic use of the inventive hydrophobic modified peptides as well as to a method for the diagnosis of liver diseases or disorders.


Find Patent Forward Citations

Loading…